Mainz Biomed B.V. (MYNZ)

Company Profile

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Company profile

Ticker

MYNZ

Exchange

NASDAQ

Website

mainzbiomed.com

CEO

Mr. Guido Baechler

Incorporated

Australia

Location

Australia

Fiscal year end

Dec 31

Industry (SIC)

Miscellaneous Electrical Machinery, Equipment & Supplies

Spectrum Brands • Sunrun • Energizer • Atkore • Fluence Energy • Novanta • Metals Acquisition • Arcadium Lithium • NorthView Acquisition • QuantumScape ...

Former names

GFL Environmental Holdings Inc.

SEC CIK

0001874252

Corporate docs

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

MYNZ stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

6-K

Report of Foreign Private Issuer

9 Oct 24

6-K

Report of Foreign Private Issuer

3 Oct 24

6-K

Mainz Biomed Reports Results of 2024 Annual General Meeting

31 May 24

D/A

$50.00 mm in equity / debt / options / securities to be acquired, sold $14.30 mm, 1 investor

10 May 24

6-K

Announcement of Annual General Meeting of

24 Apr 24

6-K

Report of Foreign Private Issuer

19 Apr 24

20-F

2023 FY

Annual report (foreign)

8 Apr 24

6-K

Report of Foreign Private Issuer

23 Feb 24

6-K

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16 Nov 23

6-K

Report of Foreign Private Issuer

15 Nov 23

Latest ownership filings

Financial summary

Financial statements Chart MYNZ financial data

Quarter (USD)	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2024

MYNZ institutional ownership history Ownership history

0.1% owned by funds/institutions

13F holders	Current	Change
Total holders	2	NEW
Opened positions	2	NEW
Closed positions	0
Increased positions	0
Reduced positions	0

13F shares	Current	Prev Q	Change
Total value	10.10 mm	0.00	NEW
Total shares	25.19 k	0.00	NEW
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Geode Capital Management	15.19 k	$6.09 mm	NEW
Wealth Quarterback	10.00 k	$4.01 mm	NEW
Proequities	0.00	$0.00

Largest transactions	Shares	Bought/sold	Change
Geode Capital Management	15.19 k	+15.19 k	NEW
Wealth Quarterback	10.00 k	+10.00 k	NEW
Proequities	0.00	0.00

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.